Immunogenicity Breakout Discussion Groups Announced at PEGS Boston, May 5-9, 2014

NEEDHAM, Mass. - April 2, 2014 - PRLog -- Cambridge Healthtech Institute (CHI) today announced details of nine breakout discussion groups, each to be hosted by a different moderator, at PEGS Boston to be held on May 5-9, 2014 at the Seaport World Trade Center. Approximately 1,600 delegates will attend.

Breakout Discussions at the “Immunogenicity for Regulatory Success” Conference:

Table: Challenges in Developing Neutralizing Antibody Assays
Moderator: Shalini Gupta, Ph.D., Director, Clinical Immunology, Amgen, Inc.

Table: Practical Application of Immunogenicity Risk Assessment
Moderator: Eric Wakshull, Ph.D., Senior Scientist and Group Leader, Bioanalytical Sciences, Genentech, Inc.

Table: Regulatory Expectations Regarding Immunogenicity Assessment
Moderator: Meena Subramanyam, Ph.D., Vice President, Translational Medicine, Biogen Idec, Inc.

Table: Dealing with Pre-Existing Positive ADA Activity in Study Patients
Moderator: Mary Birchler, Investigator, Clinical Immunology, GlaxoSmithKline, Inc.

Table: Perspectives on Immunogenicity Studies for a Biosimilar
Moderator: Alex Kudrin, MD, MBA, MRCP, MFPM, Vice President & Head, Global Development, Celltrion, Inc.

Breakout Discussions at the “Immunogenicity Prediction and Mitigation” Conference:

Table: Risk Assessment and Risk Management
Moderator: Steven J. Swanson, Ph.D., Executive Director, Medical Sciences (Clinical Immunology), Amgen, Inc.

Table: Prediction Technologies for Immunogenicity
Moderator: Tim Hickling, Ph.D., Associate Research Fellow, Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc.

Table: Immune Tolerance Approaches
Moderator: Sriram Krishnamoorthy, Ph.D., Scientist, Preclinical and Clinical Development (Hemophilia), Biogen Idec, Inc.

Table: Measures to Control Immunogenicity to Interferon Beta
Moderator: Florian Deisenhammer, Ph.D., Clinical Department of Neurology, Innsbruck Medical University

Complete event and registration details are online: http://www.pegsummit.com/streams/safety

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com.

About Cambridge Healthtech Institute (CHI):
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. www.chicorporate.com